Your browser doesn't support javascript.
loading
Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19.
Albariqi, Ahmed H; Chang, Rachel Yoon Kyung; Tai, Waiting; Ke, Wei-Ren; Chow, Michael Y T; Tang, Patricia; Kwok, Philip Chi Lip; Chan, Hak-Kim.
Affiliation
  • Albariqi AH; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Chang RYK; The Department of Pharmaceutics, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia.
  • Tai W; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Ke WR; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Chow MYT; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Tang P; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Kwok PCL; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Chan HK; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
J Aerosol Med Pulm Drug Deliv ; 34(1): 20-31, 2021 02.
Article de En | MEDLINE | ID: mdl-33179983

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / Traitements médicamenteux de la COVID-19 / Hydroxychloroquine Limites: Humans Langue: En Journal: J Aerosol Med Pulm Drug Deliv Sujet du journal: TERAPIA POR MEDICAMENTOS Année: 2021 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / Traitements médicamenteux de la COVID-19 / Hydroxychloroquine Limites: Humans Langue: En Journal: J Aerosol Med Pulm Drug Deliv Sujet du journal: TERAPIA POR MEDICAMENTOS Année: 2021 Type de document: Article Pays d'affiliation: Australie